Top 4 NASDAQ Stocks In The Biotechnology Industry With The Lowest PEG Ratio

Below are the top biotechnology stocks on the NASDAQ in terms of PEG ratio.

PDL BioPharma (NASDAQ: PDLI) has a PEG ratio of 0.35. PDL BioPharma's trailing-twelve-month revenue is $442.90 million.

Enzymotec (NASDAQ: ENZY) has a PEG ratio of 0.43. Enzymotec's trailing-twelve-month operating margin is 18.20%.

Questcor Pharmaceuticals (NASDAQ: QCOR) has a PEG ratio of 0.50. Questcor Pharma's trailing-twelve-month EPS is $4.73.

INSYS Therapeutics (NASDAQ: INSY) has a PEG ratio of 1.05. INSYS Therapeutics' trailing-twelve-month ROE is 165%.